Dibenzylpiperazine

Dibenzylpiperazine
Names
Preferred IUPAC name
1,4-Dibenzylpiperazine
Other names
DBZP
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.153.085 Edit this at Wikidata
UNII
  • InChI=1S/C18H22N2/c1-3-7-17(8-4-1)15-19-11-13-20(14-12-19)16-18-9-5-2-6-10-18/h1-10H,11-16H2 ☒N
    Key: YPUGLZQRXQQCSX-UHFFFAOYSA-N ☒N
  • InChI=1/C18H22N2/c1-3-7-17(8-4-1)15-19-11-13-20(14-12-19)16-18-9-5-2-6-10-18/h1-10H,11-16H2
    Key: YPUGLZQRXQQCSX-UHFFFAOYAP
  • C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3
  • c1ccc(cc1)CN2CCN(CC2)Cc3ccccc3
Properties
C18H22N2
Molar mass 266.388 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Dibenzylpiperazine (DBZP) is a piperazine derivative often found as an impurity in the recreational stimulant drug benzylpiperazine (BZP).[1] Presence of DBZP is a marker for low quality or badly made BZP. It can be made as a reaction byproduct during BZP synthesis, either because the reaction has been run at too high a temperature, or because an excess of benzyl chloride has been used.

Pharmacology and effects

It is not known to have any stimulant effects in its own right, although this has not been tested.

Toxicity

The toxicity of DBZP is unknown.

China

As of October 2015 DBZP is a controlled substance in China.[2]

United States

DBZP is not scheduled as a controlled substance at the federal level in the United States.[3] It is possible that it could be considered an analog BZP, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.

Florida

DBZP is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.[4]

See also

References

  1. ^ Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. (July 2010). "Purchasing 'legal highs' on the Internet--is there consistency in what you get?". QJM. 103 (7): 489–93. doi:10.1093/qjmed/hcq056. PMID 20413562.
  2. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
  3. ^ "21 CFR — Schedules of Controlled Substances §1308.11 Schedule I." Archived from the original on 2009-08-27. Retrieved 2014-12-17.
  4. ^ "Florida Statutes - Chapter 893 - Drug Abuse Prevention and Control".
Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.